Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Libert

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Clinical Chemistry|May 1, 1992
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancerJ J Body, M Paesmans, J P Sculier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Cyclophosphamide, doxorubicin and vincristine with amphotericin B in sonicated liposomes as salvage therapy for small cell lung cancerJ P Sculier, J Klastersky, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, BelgiumJ Klastersky, J P Sculier, G Bureau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861J Klastersky, J P Sculier, H Lacroix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working PartyJ P Sculier, J Klastersky, P Libert, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium)J P Sculier, J Klastersky, J P Dumont, et al.
Cancer|April 1, 1990
Evaluation of squamous cell carcinoma antigen as a new marker for lung cancerJ J Body, J P Sculier, N Raymakers, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancerJ P Sculier, J Klastersky, D Becquart, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Clinical Chemistry|May 1, 1992
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancerJ J Body, M Paesmans, J P Sculier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Cyclophosphamide, doxorubicin and vincristine with amphotericin B in sonicated liposomes as salvage therapy for small cell lung cancerJ P Sculier, J Klastersky, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, BelgiumJ Klastersky, J P Sculier, G Bureau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861J Klastersky, J P Sculier, H Lacroix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working PartyJ P Sculier, J Klastersky, P Libert, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium)J P Sculier, J Klastersky, J P Dumont, et al.
Cancer|April 1, 1990
Evaluation of squamous cell carcinoma antigen as a new marker for lung cancerJ J Body, J P Sculier, N Raymakers, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancerJ P Sculier, J Klastersky, D Becquart, et al.
Pageof 12